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a  b  s  t  r  a  c  t
Were  evaluated  individuals  divided  into  two  groups:  we studied  chronic  heart  failure  (CHF)  (19 patients
with  CHF  plus  cardiomegaly)  and  control  (12  healthy  volunteers)  during  performance  of  inspiratory
loaded  breathing  (ILB).  We  evaluated:  spirometry,  functional  capacity  through  the  six-minute  walk
test  (6MWT),  and  distribution  of  thoracoabdominal  volumes  via  optoelectronic  plethysmography  (OEP),
namely volume  variations  of  pulmonary  rib cage  (Vrc,p),  abdominal  rib cage  (Vrc,a),  and  abdomen  (Vab).
In  each  compartment,  the  percentage  contributions  of  right  and  left sides  were  also  calculated.  Dur-espiratory muscle recruitment
espiratory control
ptoelectronic pletysmography
ing  ILB,  patients  with  heart  failure  were  characterized  by  a  signiﬁcant  reduction  of the  Vrc,a  volume
variations  compared  to the  control  group.  Correlations  were  found  between  left  %Vrc,a  on the  left  side
measured  during  ILB  and left  ventricular  ejection  fraction  (r = 0.468;  p =  0.049),  and  dyspnea  after  the
6MWT  (r =  −0.878;  p <  0.01).Then,  patients  with  CHF  and  cardiomegaly  are  characterized  by  a  reduced
mobility  in left part  of the  lower  part of the  rib  cage,  that  contributes  leading  to increased  perception  of
al  edyspnea  during  submaxim
. Introduction
The main symptoms of chronic heart failure (CHF) are dyspnea
nd fatigue (Jefferies and Towbin, 2010; Pina, 2003). Various studies
ave pointed out how these symptoms are related to abnormalities
n respiratory muscles (Drexler et al., 1992; Coats, 1996) and the
resence of cardiomegaly (Olson et al., 2006). Inspiratory muscle
ysfunction has been reported as a reduction in the capacity to gen-
rate inspiratory muscle pressure and strength, a functional decline
hich can be attributed to histological and biochemical changes.
iaphragm biopsies from CHF patients have demonstrated the
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occurrence of muscle ﬁber regeneration/transformation. Other
mechanisms might include proinﬂammatory cytokine activation
and decreased blood ﬂow associated with the endothelial dysfunc-
tion characterizing CHF syndrome (Mancini et al., 1994; Mitch and
Goldberg, 1996). Some CHF patients exhibit lower maximal inspi-
ratory pressure (MIP) and inspiratory muscle endurance, factors
known to result in exercise limitation and deterioration in quality
of life, in addition to worsening patient prognosis (Dall’Ago et al.,
2006).
Studies on the role of cardiomegaly in respiratory symptoms
of CHF patients are scarce in the literature (Olson et al., 2007).
Expansion of the limited thoracic volume, where extra-pulmonary
restriction may  be caused by competition between the lungs and
heart for intrathoracic space, can lead to imbalance in the tho-
racoabdominal system. As the disease progresses and worsens,
associated with cardiomegaly, minor effort leads to more frequent
and severe dyspnea episodes and early muscle fatigue sets in (Ulrik
Open access under the Elsevier OA license.et al., 1999).
Optoelectronic plethysmography (OEP) is used to elucidate the
inﬂuence of cardiomegaly in regional distribution of ventilation in
the thoracoabdominal system of CHF patients (Aliverti and Pedotti,
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003). No studies were found in the literature using used the
echnique for this population. Therefore, the hypothesis for this
tudy is that individuals with CHF and cardiomegaly associated
ith diaphragmatic weakness exhibit volumetric differences in the
horacoabdominal system during the inspiratory loaded breathing
ILB) test when compared to healthy subjects.
The present study aimed to investigate whether alterations
n regional chest wall displacement, reﬂecting abnormalities in
espiratory muscle action, are present in CHF patients with car-




This was a cross-sectional cohort study in which a total of 31
ndividuals were evaluated and divided into two groups: CHF and
ontrol. In the CHF group, nineteen patients diagnosed with CHF
ere recruited from an outpatient clinic at a hospital cardiac center
rom May  to December 2010, according to the following inclu-
ion criteria: sedentary adults aged between 21 and 65 years; both
exes; diagnosed with CHF associated with cardiomegaly; func-
ional class II and III; hypertensive, ischemic, and Chagas disease
tiology; left ventricular ejection fraction (EF) < 45%; inspiratory
uscle weakness (predicted MIP  < 70%) (Neder et al., 1999); clin-
cal stability (>3 months); duration of symptoms > 1 year, body
ass index (BMI) < 35 kg/m2 and non-smokers or former smokers
ith a smoking history <10 packs/year. Patients with the following
haracteristics were not considered: unstable angina; myocardial
nfarction or cardiac surgery in the three months prior to the start
f the research; orthopedic diseases or respiratory comorbidities
uch as asthma and COPD. All patient medication was  optimized for
HF throughout the study. The control group consisted of twelve
olunteer participants with similar age, sex, and body mass index
o the CHF group. Control participants displayed a left ventricular
jection fraction (EF) > 50% and had no cardiac chamber abnormali-
ies, history of hypertension, lung disease, or cardiac ischemia; MIP
0% above (Neder et al., 1999) that predicted, in addition to being
edentary. All participants were instructed regarding the research
nd signed informed consent. This study was approved by the insti-
utional Human Research Ethics Committee and its registration was
ccepted by ClinicalTrial.gov under registration NCT 01292902.
.2. Functional data
.2.1. Pulmonary function and strength measurement
Inspiratory muscle strength was evaluated using a digital
anometer (MVD-300, Globalmed,  Brazil) connected to a mouth-
iece with a 2 mm opening. Each patient performed three
aneuvers with maximum variation of up to 10% between them
o achieve MIP  (Neder et al., 1999), from residual volume (RV) to
otal lung capacity (TLC). The best of the three maneuvers was
ecorded. A portable spirometer (Micro Medical, Microloop,  MK8,
ngland) was used for pulmonary function testing. Forced vital
apacity (FVC) and forced expiratory volume in one second (FEV1)
ere evaluated in accordance with recommendations of the Amer-
can Thoracic Society (American Thoracic Society, 2002).
.2.2. Functional capacity evaluation
The six-minute walk test (6MWT) was used to assess functionalapacity in terms of distance covered (6MWD) in accordance with
rotocol established by the American Thoracic Society (ATS) (2002).
he following resting parameters were evaluated before testing:
rterial pressure (Pa), heart rate (HR), oxygen saturation (SpO2Fig. 1.
measured by Onyx 9500 portable pulse oximeter), respiratory rate
(RR), and dyspnea scale (Borg Scale).
2.3. Protocol for assessment during inspiratory loaded breathing
Inspiratory loaded breathing testing was performed with a
threshold device (Threshold Inspiratory Muscle Trainer, Healthscan
Products Inc., Cedar Grove, New Jersey), mostly used for inspira-
tory muscle training in healthy subjects (Hostettler et al., 2011)
and in patients with various pathologies such as CHF (Dall’Ago
et al., 2006; Chiappa et al., 2008). This device was connected the
mouthpiece. During the three-minute-long test (De Andrade et al.,
2005), patients breathed through the mouthpiece with their noses
occluded by a noseclip, using 30% MIP. An inspiratory load of 30%
was chosen taking into consideration several studies of inspiratory
muscle training for this population (Laoutaris et al., 2004; Dall’Ago
et al., 2006; Chiappa et al., 2008). During the test, the participants
were encouraged to maintain respiratory frequency between 12
and 16 bpm. Testing was interrupted if HR increased more than
20% and/or SpO2 <88%.
2.4. Assessment of regional chest wall volumes by optoelectronic
plethysmography
Optoelectronic plethysmography (BTS Bioengineering, Italy)
measures volume changes in the thoracoabdominal system
through the placement of 89 markers formed by hemispheres cov-
ered with retro-reﬂective paper. The location of each hemisphere
is determined by anatomical references in the anterior and pos-
terior regions of the thorax and abdomen. Markers were placed
on the skin using hypoallergenic bioadhesives. Eight cameras were
placed around the patient and recorded images were transmitted to
a computer, where a three-dimensional model is formed based on
the markers OEP capture software (BTS Bioengineering, Italy). The
chest wall was divided into the following compartments (Fig. 1),
each separated into its right and left parts: pulmonary rib cage
(RCp – portion of the rib cage opposed to the lung); abdominal
rib cage (RCa – portion of the rib cage opposed to the diaphragm);
and abdomen (AB) (Aliverti and Pedotti, 2003). OEP data acqui-
sitions were performed while individuals were seated with their
arms at their sides. Data were gathered on two separate occasions:
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Table 1
Demographics data and clinical features.
Variables Groups p-Value
Control Heart failure
n (% female) 12(58.4) 19(36.0) 0.06
Age  (years) 44.83 ± 12.67 52.83 ± 8.6 0.06
BMI  (kg/m2) 23.77 ± 2.28 25.07 ± 3.7 0.3
HR  (bpm) 79.4 ± 8.7 72.9 ± 7.74 0.06
RR  (ipm) 15.75 ± 3.95 16.63 ± 2.57 0.53
LV  ejection fraction (%) 64.41 ± 9.76 33.23 ± 8.91 <0.01
DDLV 44.33 ± 2.94 64.73 ± 10.05 <0.01
SDLV 26.25 ± 2.56 55.93 ± 9.52 <0.01
FVC  (L/s) 3.66 ± 0.41 2.63 ± 0.98 0.03
%  Pred FVC 93.40 ± 13.16 76.07 ± 21.77 0.01
FEV1 (L/s) 3.03 ± 0.72 2.09 ± 0.72 0.01
%  Pred FEV1 94.43 ± 15.22 73.85 ± 22.15 0.01
Etiology [n(%)]
Chagas Disease – 10(52.63) –
Hypertensive – 5(26.31%) –
Ischemic – 4(21.05%) –
NYHA class [n(%)]
Class II – 9(47.36%) –
Class  III – 10(52.63%) –
Medications [number(% of total)]
B-blocked – 8(42.10%) –
Digitalis – 6(31.57%) –
Diuretics – 12(63.15%) –
MIP  (cmH2O) 95.55 ± 12.33 45.94 ± 15.17 <0.01
%MIP  97.80 ± 16.08 47.30 ± 14.32 <0.01
Distance (m)  in 6MWT 610.75 ± 73.95 426.47 ± 132.08 <0.01
Distance (m)  predicted for 6MWT  89.09 ± 16.64 72.02 ± 23.40 0.04
Borg  Scale before 6MWT  0.18 ± 0.02 0.06 ± 0.01 0.26
Borg  Scale after 6MWT  1.13 ± 0.35 4.27 ± 2.27 <0.01
























aalues are given as the mean ± SD. Level of signiﬁcance p < 0.05. HR = heart rate; R
econd; DDLV = diastolic diameter of left ventricle; SDLV = systolic diameter of left v
rst, during three minutes of normal breathing and then during the
nspiratory loaded breathing exercise with Threshold® ILB.
. Statistical analysis
Statistical analysis was performed by SPSS 18.0 soft-
are. The following tests and analyses were conducted:
olmogorov–Smirnov and Levene tests to assess sample normality
nd analyze intergroup homogeneity; t-test for independent
amples for intragroup comparison of the right and left sides of
ompartmental chest wall volumes and same side compartmental
olumes during normal breathing and inspiratory muscle training;
-test for dependent samples, for intragroup comparisons of
hest wall volumes of the same side during normal breathing
nd inspiratory muscle training; Pearson’s correlation analysis
o evaluate the relationship between abdominal rib cage volume
n the left side and predicted MIP, 6MWD,  and EF. Data were
escribed as mean ± standard deviation (SD). Conﬁdence intervals




The sample was calculated based on a pilot study for a power
f 90% and  ˛ = 0.05. A 40% increase in abdominal thoracic vol-
me  (Vrc,a) on the left side was observed for the control group
ompared to the group with heart failure. Clinical, demographic
nd medication characteristics are described in Table 1. Intergrouppiratory rate; FVC = forced vital capacity; FEV1 = forced expired volume in the ﬁrst
le and MIP  = maximal inspiratory pressure.
differences include lower EF (p < 0.01) and higher left ventricle sys-
tolic diameter (LVSD) and left ventricle diastolic diameter (LVDD)
(both with p < 0.01) for the CHF group compared with the con-
trol group. Controls were characterized by higher FVC%pred and
FEV1%pred than the CHF group (p = 0.03 and p = 0.01, respectively).
The control group also showed greater FVC and FEV1 in abso-
lute values (p = 0.01 for both comparisons). In relation to MIP,
control subjects exhibited higher absolute and %predicted values
(p < 0.01 for both comparisons) compared to the CHF group. Sub-
ject belonging to the control group covered an higher 6MWD  than
CHF (p < 0.01).
4.2. Regional distribution of chest wall volumes
Table 2 shows the comparison of regional chest wall volume
distribution between normal breathing and ILB on the same side
of the thoracoabdominal system for each of the groups, as well
as a between-group analysis. When analyzing each group sepa-
rately, a signiﬁcant increase was observed for all thoracoabdominal
compartments, on both sides during ILB for the two  groups. CHF
patients showed signiﬁcantly lower Vrc,a variations (both sides)
compared to the control group during ILB. Table 3 displays the com-
parison between right and left percentages of volume variations
for each compartment of the chest wall during normal breath-
ing and IMT  for each group. Signiﬁcant differences between right
and left sides for variations of Vrc,a, Vab, and Vcw were present
during the performance of ILB in the CHF group (p < 0.01, p < 0.01,
and p = 0.04, respectively). Percentage contribution of left and right
parts, respectively, was: 45.30 ± 9.10% and 54.33 ± 12.9% in Vrc,a,
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Table  2
Comparison of volume variations of the six compartments of the thoracoabdominal system during quiet breathing and during inspiratory loaded breathing.
Lung volumes
(compartments)
Control group Heart failure group Control group × heart
failure group (left side)
Control group × heart
failure group (right side)
Left side p Right side p Left side p Right side p p p
Vrc,p (Liters)
QB 0.08 ± 0.03 <0.01* 0.09 ± 0.04 <0.01* 0.09 ± 0.05 0.03* 0.09 ± 0.04 <0.01* 0.639 0.85
ILB  0.25 ± 0.08 0.26 ± 0.09 0.17 ± 0.11 0.18 ± 0.09 0.08 0.06
Vrc,a  (Liters)
QB 0.09 ± 0.12 <0.01* 0.07 ± 0.06 <0.01* 0.04 ± 0.02 <0.01* 0.04 ± 0.02 0.01* 0.06 0.06
ILB  0.17 ± 0.06 0.20 ± 0.15 0.08 ± 0.05 0.10 ± 0.08 0.01* 0.04*
Vab  (Liters)
QB 0.12 ± 0.01 0.03* 0.13 ± 0.01 0.02* 0.12 ± 0.06 0.04* 0.12 ± 0.04 0.01* 0.86 0.72
ILB  0.27 ± 0.02 0.28 ± 0.02 0.20 ± 0.01 0.23 ± 0.19 0.36 0.53
Vcw  (Liters)
QB 0.26 ± 0.08 <0.01* 0.27 ± 0.08 <0.01* 0.25 ± 0.10 <0.01* 0.26 ± 0.08 <0.01* 0.82 0.88
ILB  0.65 ± 0.3 0.67 ± 0.3 0.47 ± 0.25 0.52 ± 0.28 0.95 0.15
QB – quiet breathing; ILB – inspiratory loaded breathing (30%Pimax); Vrc,p – pulmonary rib cage volume; Vrc,a – abdominal rib cage volume; Vab – abdominal volume; Vcw
–  chest wall volume. Values are expressed as mean ± SD. Consider signiﬁcant as p < 0.05*. Test t for dependent samples for into the same group and Test t for independent

















sn the ﬁrst four columns can observe the behavior of the distribution of total vo
ompartment when it is compared, along the QB and ILB. The last two columns re
horacoabdominal system for both the QB and for the ILB.
5.00 ± 6.52% and 55.00 ± 6.52% in Vab, and 48.04 ± 5.38% and
2 ± 5.31% in total chest wall volume (Vcw).
.3. Correlation of % Vra on the left side with the functional data
A signiﬁcant negative correlation (r = −0.878 and p < 0.01) was
ound between Borg Scale after the 6MWT  and the Vrc,a (left side)
uring ILB (Fig. 2). A linear correlation at the limit of signiﬁcance
r = 0.468 and p = 0.049) was present between Vrc,a (left side) and
V ejection fraction during ILB (Fig. 3). No signiﬁcant correlations
ere recorded between variations of Vrc,a (left side) during IMT
able 3
ercentage contribution of the right and left side of each of the six compartments
f  the chest wall.
Control group p-Value Heart failure group p-Value
Quiet breathing
Vrc,p (%)
Left side 49.67 ± 3.64 0.348 50.20 ± 3.43 0.714
Right side 51.35 ± 4.86 49.80 ± 3.43
Vrc,a (%)
Left side 50.95 ± 4.70 0.329 47.52 ± 5.93 0.273
Right side 49.03 ± 4.7 50.77 ± 9.40
Vab (%)
Left side 48.40 ± 5.95 0.207 47.09 ± 12.7 0.219
Right side 51.56 ± 5.92 50.41 ± 5.80
Vcw (%)
Left side 49.38 ± 2.30 0.214 49.15 ± 2.79 0.072
Right side 50.58 ± 2.30 50.83 ± 2.79
Inspiratory loaded breathing (30% MIP)
Vrc,p (%)
Left side 49.67 ± 3.64 0.348 49.09 ± 10.39 0.273
Right side 51.35 ± 4.86 52.88 ± 10.00
Vrc,a (%)
Left side 50.81 ± 5.11 0.583 45.30 ± 9.10 <0.01*
Right side 49.60 ± 5.5 54.33 ± 12.97
Vab (%)
Left side 48 ± 3.86 0.053 45.00 ± 6.52 <0.01*
Right side 51.46 ± 4.64 55.00 ± 6.52
Vcw (%)
Left side 49.67 ± 4.45 0.214 48.04 ± 5.38 0.043*
Right side 51.15 ± 3.18 52 ± 5.31
rp – pulmonary rib cage volume; Vra – abdominal rib cage volume; Va – abdominal
olume; Vcw – chest wall volume. Values are expressed as mean ± SD. Consider
igniﬁcant as p < 0.05. Test t for independent samples. within the same group and same for right or left side of the thoracoabdominal
t the behavior of these variables between the groups and to the same side of the
and 6MWD  (r = −0.064 and p = 0.79), LSVE (r = 0.03 and p = 0.89),
and LVSD (r = −0.11 and p = 0.695).
5. Discussion
5.1. Major ﬁnding
The present study demonstrates signiﬁcant differences in
regional distribution of thoracoabdominal volumes between
patients with heart failure associated with cardiomegaly and
healthy controls. More speciﬁcally, the left side of the lower rib
cage is characterized by lower displacement during ILB breathing.
Regional distribution differences in chest wall volume are corre-
lated with other functional parameters, namely left ventricular
ejection fraction and dyspnea.
5.2. Pulmonary function, inspiratory muscle strength, 6MWT  and
Borg Scale
Patients with CHF were characterized by impaired lung func-
tion, as shown by the lower FVC, FEV1, and FEF values compared
to healthy individuals. Some authors attribute these ﬁndings to
respiratory muscle weakness, lung ﬂuid imbalance, and exagger-
ated neurohumoral activity (Rutten et al., 2006; Johnson et al.,
2000; Daganou et al., 1999; Puri et al., 1994). Agostoni et al.
Fig. 2.













































2000) proposed an inﬂuence of cardiomegaly on pulmonary func-
ion. According to this study, patients with cardiomegaly, deﬁned
y an increase in cardiothoracic index, showed lower FEV1 and
VC. In the present study, cardiomegaly was determined by the
ncrease in left ventricular systolic and diastolic diameters. This
mpliﬁcation in cardiac chambers could be considered a compet-
ng factor with pulmonary parenchyma, leading to deterioration
n pulmonary function (Olson et al., 2006, 2007; Agostoni et al.,
000). In relation to inspiratory muscle strength, MIP  < 70% was
sed as an inclusion criterion for the CHF group. Respiratory mus-
le weakness and physical deconditioning may  be involved in the
ncrease in respiratory work during hyperpnea at the time of task
erformance (Witte and Clark, 2005; Clark et al., 1995). Reduced
unctional capacity, assessed by the 6MWT,  associated with less
trength and endurance generated by inspiratory muscles are fac-
ors that worsen CHF patient prognosis and survival (Meyer et al.,
001). This study recorded a decrease in distance covered and a
ise in the Borg index after the 6MWT  for CHF group patients when
ompared to healthy subjects.
.3. Distribution of chest wall volume variations
During ILB, the CHF group displayed smaller volume variations
n the lower rib cage compared to controls. Since this compartment
eﬂects direct action of the diaphragm on the rib cage, reduced val-
es observed in CHF patients during ILB demonstrate its impaired
ction in developing inspiratory pressure. This is particularly evi-
ent during ILB, that is, a situation requiring a signiﬁcant rise in
nspiratory muscle pressure (Meyer et al., 2001). It is important to
ote that decreased lower rib cage displacement in CHF patients
s not associated to reduced overall chest wall volume variations.
his suggests the presence of compensatory mechanisms in the
pper rib cage and abdominal compartments Aliverti et al. (1997)
bserved that, during exercise, abdominal and rib cage muscles play
 double role of preventing costly rib cage distortions and unload-
ng the diaphragm so that it acts as a ﬂow generator. Furthermore,
he rib cage and abdominal muscles assume the task of develop-
ng the pressures required to move the rib cage and abdomen,
espectively.
This mechanism could be the base of similar compensatory
echanisms observed in the CHF group. Another original ﬁnding
n the present study was that in both compartments submitted
o the action of the diaphragm, namely the lower rib cage and
he abdomen, during ILB displacement of the left side was sig-
iﬁcantly lower than the right in CHF patients, but not among
ontrols. A possible explanation is that cardiomegaly would limit
ffective diaphragmatic displacement on the left side, where a heart
ith increased volume might represent a mechanical load for the& Neurobiology 180 (2012) 269– 274 273
diaphragm, altering its normal return to its relaxed position. This
hypothesis is supported by Olson et al. (2006) who studied the rela-
tionship between cardiac and pulmonary volume in the thoracic
cavity of 44 individuals with CHF compared to healthy individ-
uals via radiographic analysis. These authors observed a strong
correlation between heart size and pulmonary volume reduction
for CHF patients. They also suggest that increased cardiac volume
and reduced pulmonary volume could contribute to the rapid and
shallow breathing frequently observed in this population, partic-
ularly during exercise. In another study, the same group (Olson
et al., 2007) evaluated pulmonary function in CHF patients with
cardiomegaly and observed lower values of FVC, FEV1, FEV1/FVC,
and FEF 25–75%. More recently, Olson and Johnson (2011) studied
the inﬂuence of cardiomegaly on respiratory disorder during exer-
cise in patients with CHF and showed a strong correlation between
cardiac volume in tidal volume changes and respiratory frequency
during exercise.
5.4. Study limitations
A limitation of this study is the absence of an additional group for
comparison, composed of patients with cardiomegaly related CHF
without inspiratory muscle weakness, enabling effects for each of
these variables to be evsluated in separadely. However, our data
can be extrapolated for patients with CHF associated with muscle
weakness, elements commonly found in patients with CHF func-
tional class II or III (NYHA). In addition, the present study did not
correlate thoraco-abdominal system volumes with variables from
maximal cardiopulmonary exercise test (VO2-Oxygen uptake (Oxy-
gen consumption) or VE/VCO 2, ventilatory equivalents for CO2)
and with DLCO (Lung diffusion for carbon monoxide), which could
better elucidate behavior of these volumes during maximum respi-
ratory demand. This correlation is an important point to be consider
in the future studies as well concomitant OEP assessment dur-
ing submaximal exercise. The submaximal exercise selected in the
present study was the six-minute walk test, since it corresponds to
the demands of activities of daily living. As such, OEP evaluation of
thoracoabdominal system volumes concomitant to this test would
not be possible.
5.5. Clinical implications
Cardiomegaly and inspiratory muscle weakness are common in
patients with CHF. However, the exact action mechanisms of these
two associated or isolated factors in the determination of respira-
tory symptoms are still unknown. According to our study, lower
chest wall expansion in the diaphragmatic region would lead to
an increased perception of dyspnea during submaximal exercise
in this population. Moreover, changes observed in the pattern of
regional chest wall volume distribution in CHF patients compared
to healthy individuals could serve as a base for other prospective
studies using inspiratory muscle training (IMT) and analyzing its
effects on redistribution of pulmonary ventilation in these patients.
In conclusion, in CHF patients with cardiomegaly, asymmetric
expansion of the lower rib cage compartment is related to dysp-
nea and cardiac impairment. This suggests that signiﬁcant interplay
exists between cardiac and respiratory function, up to perceived
effort sensation levels.
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